• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

Dolores “Dee” Holden Norris (1946–2025), Ted’s wife, championed the award and the standards of clinical excellence it represents. In December 2025, the International Alliance paid tribute to Dee — nurse, advocate, co-founder of the Alliance, and a driving force behind the multidisciplinary model of ALS/MND care.

Working alongside Ted, she helped transform how ALS/MND care is delivered worldwide. At a time when patients were often offered little more than prognosis, they envisioned something fundamentally different: coordinated, team-based care grounded in clinical excellence and compassion. Their work helped establish the global standard for multidisciplinary ALS/MND clinics and laid the foundation for the collaborative international community that exists today.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period will open on July 1. 

Primary Sidebar

  • Frank Taylor, USA

    Frank Taylor, USA

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Purningam Jacob, India

    Purningam Jacob, India

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Jason Goodman, USA

    Jason Goodman, USA

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • Susan Anderson, USA

    Susan Anderson, USA

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Denis Blais, Canada

    Denis Blais, Canada

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Len Johnrose, England

    Len Johnrose, England

  • Phil Rossall, UK

    Phil Rossall, UK

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Dick Dayton, USA

    Dick Dayton, USA

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Rosie Riley, USA

    Rosie Riley, USA

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Sally Pauls, USA

    Sally Pauls, USA

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login